- 商品介绍
- 规格参数
- 包装参数
General description
In clinical development for the treatment of dry eye and chronic lung disease, such as cystic fibrosis
Biochem/physiol Actions
Diquafosol (Up4U, INS365) is a selective purinergic receptor P2Y2 agonist (EC50 = 100 nM/P2Y2, 400 nM/P2Y4, 20 μM/P2Y6, >100 μM/P2Y1 by calcium mobilization using respective 1321N P2Y subtype transfectants). In addition to its in vivo efficacy in anmial dry eye models, diquafosol is also shown to enhance mucociliary clearance in sheep and stimulate vaginal moisture in ovariectomized rabbits.
P2Y2/P2Y4 purinoceptor agonist: EC50 = 0.10 μM at P2Y2, 0.4 μM at P2Y4 (20 μM at P2Y6) in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y1, P2Y2, P2Y4 and P2Y6
| Quality Segment | 100 |
| assay | >95% (HPLC) |
| form | powder |
| optical activity | [α]/D -12.0 to -8.0°, c = 1.0 in H2O |
| color | white to beige |
| solubility | H2O: 2 mg/mL, clear |
| storage temp. | −20°C |
| SMILES string | [Na].[Na].[Na].[Na].[P](=O)(O[P](=O)(O[P](=O)(OC[C@H]3O[C@H]([C@@H]([C@@H]3O)O)N4C=CC(=O)NC4=O)O)O)(O[P](=O)(OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)N2C=CC(=O)NC2=O)O)O |
| InChI | 1S/C18H26N4O23P4.4Na/c23-9-1-3-21(17(29)19-9)15-13(27)11(25)7(41-15)5-39-46(31,32)43-48(35,36)45-49(37,38)44-47(33,34)40-6-8-12(26)14(28)16(42-8)22-4-2-10(24)20-18(22)30;;;;/h1-4,7-8,11-16,25-28H,5-6H2,(H,31,32)(H,33,34)(H,35,36)(H,37,38)(H,19,23,29)(H,20 |
| InChI key | MHPMESDJCUICEY-FNXFGIETSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
询价
-
¥ 1779.22
-
¥ 3109.49
-
询价
-
¥ 6894.69
-
询价
-
询价
-
询价
-
¥ 1653.62
-
¥ 3796.67
-
¥ 66743.99
-
询价
-
¥ 44224.19
-
¥ 14985.93
-
¥ 15537.49
-
询价
-
¥ 99441.38
-
¥ 14722.42
-
询价
微信小程序
7X24小时在线咨询